Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Rachel Howard
  • October 6, 2017
  • Articles

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Deep Dive - MINT: opportunities in ‘frontier’ markets?

Published in Pharmaphorum’s Deep Dive magazine October 2017

According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them. What are the prospects for pharma in MINT? Research Partnership’s Rachel Howard and Sue Rees investigate the pros and cons.

read more »

  • Posted by Marc Yates
  • September 27, 2017
  • Articles

Ageing Asia: What does the future hold?

Ageing Asia: What does the future hold?

Published in eyeforpharma September 2017 by Marc Yates

Over the last 30 years, Asia’s economic growth has resulted in improved education and healthcare across a broad base of the population, contributing to declining fertility and increasing life expectancy. However, in turn, such changing demographic features are set to have profound repercussions on the continent’s socio-economic and healthcare set-up in the coming decades. 

read more »

  • Posted by Julie Denny
  • August 16, 2017
  • Articles

Global health care specialists from coast to coast

Global health care specialists from coast to coast

Published in Quirk's Faces of Marketing Research August 2017

Research Partnership is celebrating 20 years in business this year with expansion across the U.S., opening new offices in San Francisco and New York. With headquarters in Philadelphia and a satellite office in Boston, Research Partnership is now expertly placed to support pharma from West to East coast. We shine a light on four of our key faces of research.

read more »

  • Posted by Marc Yates
  • August 16, 2017
  • Articles

Navigating South Korea’s Healthcare Paradox

Navigating South Korea’s Healthcare Paradox

Published in eyeforpharma August 2017 by Marc Yates

In recent years, we have witnessed an explosion of interest among our pharmaceutical clients in conducting research in South Korea. Some emerging market analysts have suggested a ‘K’ should be added to BRIC, reflecting the country’s burgeoning economic status and its increasingly inclusion in global studies, not just regional Asia Pacific or emerging market studies. Indeed, there is ongoing debate about whether South Korea can still be considered ‘emerging’ as it is a growing player in the pharmaceutical industry in its own right. 
 
As well as looking at South Korea’s healthcare outlook in more detail, in this article we also ask why the country lies at the extremes of two conflicting global health indicators – longest life expectancy and highest suicide rates. 

read more »

  • Posted by Mariel Metcalfe
  • July 14, 2017
  • Articles

Living with Lupus: Breaking the Silence

Living with Lupus: Breaking the Silence

Published in eyeforpharma July 2017 by Mariel Metcalfe

Lupus is an almost invisible disease, yet can have considerable impact on patients’ quality of life, but there is much that pharma can do to help.

read more »